Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant

Cited by (629)

Items 201–300 of 629

1. Humoral Immunity against SARS-CoV-2 and the Impact on COVID-19 Pathogenesis
   Eun-Jin Lee, Ji Eun Oh · 2021 · Molecules and Cells
2. Meta-Analysis and Structural Dynamics of the Emergence of Genetic Variants of SARS-CoV-2
   Nicolas Castonguay, Wandong Zhang, Marc‐André Langlois · 2021 · Frontiers in Microbiology
3. Beta RBD boost broadens antibody-mediated protection against SARS-CoV-2 variants in animal models
   Daniel J. Sheward, Marco Mandolesi, Egon Urgard, Changil Kim, Leo Hanke, Laura Perez Vidakovics, Alec P. Pankow, Natalie L. Smith, Xaquín Castro Dopico, Gerald M. McInerney et al. · 2021 · Cell Reports Medicine
4. A tale of two variants: Spread of SARS-CoV-2 variants Alpha in Geneva, Switzerland, and Beta in South Africa
   Christian Lorenz Althaus, Stéphanie Baggio, Martina L. Reichmuth, Emma B. Hodcroft, Julien Riou, Richard A. Neher, Frédérique Jacquérioz, Hervé Spechbach, Julien Salamun, Pauline Vetter et al. · 2021 · medRxiv
5. COVID-19 vaccines: their effectiveness against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its emerging variants
   Rashed Noor, Saadia Shareen, Muntasir Billah · 2022 · Bulletin of the National Research Centre/Bulletin of the National Research Center
6. Carbon nanotubes in perovskite solar cells: A comprehensive review of recent developments and future directions
   Muhammad Azam Qamar, Komal Aroosh, Aqsa Nawaz, Majed Y. A. Almashnowi, M. Hisham Alnasir · 2024 · Synthetic Metals
7. Isolation and characterization of SARS-CoV-2 Beta variant from UAE travelers
   Pragya Dhruv Yadav, Prasad Sarkale, Alpana Razdan, Nivedita Gupta, Dimpal A. Nyayanit, Rima Rakeshkumar Sahay, Varsha Atul Potdar, Deepak Y. Patil, Shreekant Baradkar, Abhinendra Kumar et al. · 2021 · Journal of Infection and Public Health
8. Exploring the immune evasion of SARS-CoV-2 variant harboring E484K by molecular dynamics simulations
   Leyun Wu, Cheng Peng, Yanqing Yang, Yulong Shi, Liping Zhou, Zhijian Xu, Weiliang Zhu · 2021 · Briefings in Bioinformatics
9. COVID-19 Vaccine Platforms: Challenges and Safety Contemplations
   Hadeel T. Al-Jighefee, Hoda Najjar, Muna Nizar Ahmed, Abeer Qush, Sara Awwad, Layla Kamareddine · 2021 · Vaccines
10. Effectiveness of BNT162b2 mRNA COVID-19 vaccine against SARS-CoV-2 variant Beta (B.1.351) among persons identified through contact tracing in Israel: A prospective cohort study
    Shepherd Roee Singer, Frederick J. Angulo, David L. Swerdlow, John M. McLaughlin, Itay Hazan, Netanel Ginish, Emilia Anis, Ella Mendelson, Orna Mor, Neta S. Zuckerman et al. · 2021 · EClinicalMedicine
11. HIV and SARS-CoV-2 Co-infection: Epidemiological, Clinical Features, and Future Implications for Clinical Care and Public Health for People Living with HIV (PLWH) and HIV Most-at-Risk Groups
    Daniel Kwakye Nomah, Juliana Reyes‐Urueña, Josep Maria Llibre, Juan Ambrosioni, Fabiana Ganem, José Ma Miró, Jordi Casabona · 2022 · Current HIV/AIDS Reports
12. Research progress on vaccine efficacy against SARS-CoV-2 variants of concern
    Lianlian Bian, Jianyang Liu, Fan Gao, Qiushuang Gao, Qian He, Qunying Mao, Xing Wu, Miao Xu, Zhenglun Liang · 2022 · Human Vaccines & Immunotherapeutics
13. A Bivalent COVID-19 Vaccine Based on Alpha and Beta Variants Elicits Potent and Broad Immune Responses in Mice against SARS-CoV-2 Variants
    Rui Wang, Chunyun Sun, Juan Ma, Chulin Yu, Desheng Kong, Meng Chen, Xuejie Liu, Dandan Zhao, Shuman Gao, Shuyuan Kou et al. · 2022 · Vaccines
14. Efficacy and Safety of a Protein-Based SARS-CoV-2 Vaccine
    Ehsan Mostafavi, Sana Eybpoosh, Mohammad Karamouzian, Malahat Khalili, Saiedeh Haji‐Maghsoudi, ‪Mostafa Salehi-Vaziri, Ali Khamesipour, Tahmineh Jalali, Mehran Nakhaeizadeh, Hamid Pour Sharifi et al. · 2023 · JAMA Network Open
15. A review of the safety and efficacy of current COVID-19 vaccines
    Zehong Huang, Yingying Su, Tianying Zhang, Ningshao Xia · 2022 · Frontiers of Medicine
16. A Capsid Virus-Like Particle-Based SARS-CoV-2 Vaccine Induces High Levels of Antibodies and Protects Rhesus Macaques
    Ariane Volkmann, Gerrit Koopman, Petra Mooij, Ernst J. Verschoor, Babs E. Verstrepen, Willy M J M Bogers, Manja Idorn, Søren R. Paludan, Søren Vang, Morten Agertoug Nielsen et al. · 2022 · Frontiers in Immunology
17. Multi-antigen intranasal vaccine protects against challenge with sarbecoviruses and prevents transmission in hamsters
    Ankita Leekha, Arash Saeedi, K M Samiur Rahman Sefat, Monish Kumar, Melisa A. Martinez-Paniagua, Adrian Damian, Rohan SUDHIR Kulkarni, Kate Reichel, Ali Rezvan, Shalaleh Masoumi et al. · 2024 · Nature Communications
18. Effect of SARS-CoV-2 Mutations on the Efficacy of Antibody Therapy and Response to Vaccines
    Ahmed Yaqinuddin, Areez Shafqat, Junaid Kashir, Khaled Manae AlKattan · 2021 · Vaccines
19. Counting on COVID-19 Vaccine: Insights into the Current Strategies, Progress and Future Challenges
    Ramesh J. L. Kandimalla, Pratik Chakraborty, Jayalakshmi Vallamkondu, Anupama Chaudhary, Sonalinandini Samanta, P. Hemachandra Reddy, Vincenzo De Feo, Saikat Dewanjee · 2021 · Biomedicines
20. Longevity of vaccine protection: Immunological mechanism, assessment methods, and improving strategy
    Zhian Chen, Xin Gao, Di Yu · 2022 · Open Research (University of Surrey)
21. A universal SARS‐CoV DNA vaccine inducing highly cross‐reactive neutralizing antibodies and T cells
    Sofia Appelberg, Gustaf Ahlén, Jingyi Yan, Negin Nikouyan, Sofie Weber, Olivia J. Larsson, Urban Höglund, Soo Aleman, Friedemann Weber, Emma Perlhamre et al. · 2022 · EMBO Molecular Medicine
22. Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 Protein Vaccine
    Gustavo H. Dayan, Nadine Rouphael, Stephen R. Walsh, Aiying Chen, Nicole A. Grunenberg, Mary Allen, Johannes Antony, Kwaku Poku Asante, Amit Suresh Bhate, Tatiana H. Beresnev et al. · 2022 · The Lancet Respiratory Medicine
23. The challenge of emerging SARS-CoV-2 mutants to vaccine development
    Rong Li, Jun Liu, Hui Zhang · 2021 · Journal of genetics and genomics/Journal of Genetics and Genomics
24. Interpreting estimates of coronavirus disease 2019 (COVID-19) vaccine efficacy and effectiveness to inform simulation studies of vaccine impact: a systematic review
    Natsuko Imai, Alexandra B. Hogan, Lucy R Williams, Anne Cori, Tara D. Mangal, Peter Winskill, Lilith K. Whittles, Oliver John Watson, Edward Knock, Marc Baguelin et al. · 2021 · Wellcome Open Research
25. Emergency use of COVID-19 vaccines recommended by the World Health Organization (WHO) as of June 2021
    Xiaoni Cui, Pengxiang Wang, Zhun Wei · 2021 · Drug Discoveries & Therapeutics
26. Factors Affecting the Antibody Immunogenicity of Vaccines against SARS-CoV-2: A Focused Review
    Zhangkai Jason Cheng, Mingshan Xue, Peiyan Zheng, Jiali Lyu, Zhiqing Zhan, Haisheng Hu, Yong Zhang, Xiaohua Douglas Zhang, Baoqing Sun · 2021 · Vaccines
27. HIV and SARS-CoV-2 Co-infection: Epidemiological, Clinical Features, and Future Implications for Clinical Care and Public Health for People Living with HIV (PLWH) and HIV Most-at-Risk Groups
    Daniel Kwakye Nomah, Juliana Reyes‐Urueña, Josep Maria Llibre, Juan Ambrosioni, Fabiana Ganem, José Ma Miró, Jordi Casabona · 2021 · Current HIV/AIDS Reports
28. Vaccines against SARS-CoV-2 variants and future pandemics
    Taeyoung Park, Hyogyeong Hwang, Suhyeong Moon, Sang Gu Kang, Seunghyup Song, Young Hun Kim, Hanbi Kim, Eun‐Ju Ko, Soon‐Do Yoon, Sang‐Moo Kang et al. · 2022 · Expert Review of Vaccines
29. SARS-CoV-2 immunity and vaccine strategies in people with HIV
    Claire Mullender, Kelly da Costa, Aljawharah Alrubayyi, Sarah Lilian Pett, Dimitra Peppa · 2022 · Oxford Open Immunology
30. Anti-COVID-19 Vaccination in Patients with Autoimmune-Autoinflammatory Disorders and Primary/Secondary Immunodeficiencies: The Position of the Task Force on Behalf of the Italian Immunological Societies
    Raffaele D’Amelio, Riccardo Asero, Marco Antonio Cassatella, Bruno Laganà, Claudio Lunardi, Paola Migliorini, Roberto Nisini, Paola Parronchi, Isabella Quinti, Vito Racanelli et al. · 2021 · Biomedicines
31. Immune Evasive Effects of SARS-CoV-2 Variants to COVID-19 Emergency Used Vaccines
    Yandi Zhang, Jo‐Lewis Banga Ndzouboukou, Mengze Gan, Xiaosong Lin, Xionglin Fan · 2021 · Frontiers in Immunology
32. Novel case of takotsubo cardiomyopathy following COVID-19 vaccination
    Caitlin Stewart, David T. Gamble, Dana K. Dawson · 2022 · BMJ Case Reports
33. Development of antibody resistance in emerging mutant strains of SARS CoV‐2: Impediment for COVID‐19 vaccines
    Narasimha Murthy Beeraka, Olga A. Sukocheva, Elena Lukina, Junqi Liu, Ruitai Fan · 2022 · Reviews in Medical Virology
34. Chemical and biological characterization of vaccine adjuvant QS-21 produced via plant cell culture
    Xiangmin Lv, Jesse Martin, Heather S. Hoover, Bishnu Prasad Joshi, Margaret K. Wilkens, David A. Ullisch, Thomas Leibold, John Juchum, Sanket Revadkar, Barbara Kalinovska et al. · 2024 · iScience
35. Current Progress, Challenges and Prospects in the Development of COVID-19 Vaccines
    Congrui Zhu, Shengmei Pang, Jiaqi Liu, Qiangde Duan · 2024 · Drugs
36. Recombinant protein subunit SARS-CoV-2 vaccines formulated with CoVaccine HT™ adjuvant induce broad, Th1 biased, humoral and cellular immune responses in mice
    Chih-Yun Lai, Albert To, Teri Ann S. Wong, Michael M. Lieberman, David E. Clements, James T. Senda, Aquena H. Ball, Laurent Pessaint, Hanné Andersen, Wakako Furuyama et al. · 2021 · Vaccine X
37. Interplay between Emerging SARS-CoV-2 Variants and Pandemic Control
    Kathleen Maletic Neuzil · 2021 · New England Journal of Medicine
38. Specific Protein Antigen Delivery to Human Langerhans Cells in Intact Skin
    Mareike Rentzsch, Robert Wawrzinek, Claudia Zelle‐Rieser, Helen Strandt, Lydia Bellmann, Felix F. Fuchsberger, Jessica Schulze, Jil A. Busmann, Juliane Rademacher, Stephan Sigl et al. · 2021 · Frontiers in Immunology
39. Coronavirus disease 2019 vaccine effectiveness among a population-based cohort of people living with HIV
    Catharine Chambers, Hasina Samji, Curtis Cooper, Cecilia Theresa Costiniuk, Naveed Zafar Janjua, Abigail E. Kroch, Gordon Arbess, Anita C. Benoit, Sarah A. Buchan, Hannah Chung et al. · 2022 · AIDS
40. Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern
    Thibault Fiolet, Yousra Kherabi, Conor James MacDonald, Jade Ghosn, Nathan Peiffer‐Smadja · 2021
41. National strategies for vaccination against COVID‐19 in people living with HIV in Central and Eastern European region
    David Jilich, Agata Skrzat‐Klapaczyńska, Lukáš Fleischhans, Dominik Bursa, Sergii Antoniak, Tatevik Balayan, Josip Begovać, Alma Cicic, Gordana Dragović, Deniz Goekengin et al. · 2021 · HIV Medicine
42. Molecular variants of SARS-CoV-2: antigenic properties and current vaccine efficacy
    Amirmasoud Rayati Damavandi, Razieh Dowran, Sarah Al Sharif, Fatah Kashanchi, Reza Jafari · 2022 · Medical Microbiology and Immunology
43. A SARS-CoV-2 Wuhan spike virosome vaccine induces superior neutralization breadth compared to one using the Beta spike
    Yme Ubeles van der Velden, Marloes Grobben, Tom G. Caniels, Judith A. Burger, Meliawati Poniman, Melissa Oomen, Esther Siteur-van Rijnstra, Khadija Tejjani, Denise Guerra, Ronald Kempers et al. · 2022 · Scientific Reports
44. Classifying COVID-19 Variants Based on Genetic Sequences Using Deep Learning Models
    Sayantani Basu, Roy H. Campbell · 2022 · Springer series in reliability engineering
45. Publication trends of research on COVID-19 and host immune response: A bibliometric analysis
    Yun Qiang Xia, Ren-qi Yao, Pengyue Zhao, Zhengbo Tao, Liyu Zheng, Huiting Zhou, Yong-ming Yao, Xuemin Song · 2022 · Frontiers in Public Health
46. Application of Traditional Vaccine Development Strategies to SARS-CoV-2
    Halie M. Rando, Ronan Lordan, Alexandra J. Lee, Amruta S. Naik, Nils Wellhausen, Elizabeth Sell, Likhitha Kolla, Anthony Gitter, Casey S. Greene, Vikas Bansal et al. · 2023 · mSystems
47. The resurgence risk of COVID-19 in China in the presence of immunity waning and ADE: A mathematical modelling study
    Weike Zhou, Biao Tang, Yao Bai, Yiming Shao, Yanni Xiao, Sanyi Tang · 2022 · Vaccine
48. Combination Respiratory Vaccine Containing Recombinant SARS-CoV-2 Spike and Quadrivalent Seasonal Influenza Hemagglutinin Nanoparticles with Matrix-M Adjuvant
    Michael J. Massare, Nita Patel, Bin Zhou, Sonia M. Maciejewski, Rhonda Flores, Mimi Guebre‐Xabier, Jing-Hui Tian, Alyse D. Portnoff, Louis F Fries, Vivek Shinde et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
49. Effect of SARS-CoV-2 spike mutations on animal ACE2 usage and in vitro neutralization sensitivity
    Weitong Yao, Danting Ma, Haimin Wang, Xiaojuan Tang, Chengzhi Du, Hong Pan, Chao Li, Hua Lin, Michael Farzan, Jincun Zhao et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
50. Impact of Chronic HIV Infection on SARS-CoV-2 Infection, COVID-19 Disease and Vaccines
    Yexin Yang, Akiko Iwasaki · 2021 · Current HIV/AIDS Reports
51. Vaccination with SARS-CoV-2 variants of concern protects mice from challenge with wild-type virus
    Fatima Amanat, Shirin Strohmeier, Philip S. Meade, Nicholas Dambrauskas, Barbara Mühlemann, Derek J. Smith, Vladimir I. Vigdorovich, D. Noah Sather, Lynda Coughlan, Florian Krammer · 2021 · PLoS Biology
52. Safety and immunogenicity of NVX-CoV2373 (TAK-019) vaccine in healthy Japanese adults: Interim report of a phase I/II randomized controlled trial
    Taisei Masuda, Kyoko Murakami, Kenkichi Sugiura, Sho Sakui, Ron P. Schuring, Mitsuhiro Mori · 2022 · Vaccine
53. A Multivalent Vaccine Based on Ferritin Nanocage Elicits Potent Protective Immune Responses against SARS-CoV-2 Mutations
    Seong A Kim, Seohyun Kim, Gi Beom Kim, Jiyoung Goo, Nayeon Kim, Yeram Lee, Gi‐Hoon Nam, Seungho Lim, Taeerk Kim, Ki Hwan Chang et al. · 2022 · International Journal of Molecular Sciences
54. COVID-19 Vaccine Effectiveness Against Progression to In-Hospital Mortality in Zambia, 2021–2022
    Duncan M Chanda, Jonas Zajac Hines, Megumi Itoh, Sombo Fwoloshi, Peter A. Minchella, Khozya Zyambo, Suilanji Sivile, Davies Kampamba, Bob Chirwa, Raphael Chanda et al. · 2022 · Open Forum Infectious Diseases
55. HIV skews the SARS-CoV-2 B cell response towards an extrafollicular maturation pathway
    Robert Krause, Jumari Snyman, Shi-Hsia Hwa, Daniel Muema, Farina Karim, Yashica Ganga, Abigail Ngoepe, Yenzekile Zungu, Inbal Gazy, Mallory P. Bernstein et al. · 2022 · eLife
56. Safety and immunogenicity of a third dose of COVID-19 protein subunit vaccine (CovovaxTM) after homologous and heterologous two-dose regimens
    Sitthichai Kanokudom, Jira Chansaenroj, Nungruthai Suntronwong, Suvichada Assawakosri, Ritthideach Yorsaeng, Pornjarim Nilyanimit, Ratchadawan Aeemjinda, Nongkanok Khanarat, Preeyaporn Vichaiwattana, Sirapa Klinfueng et al. · 2022 · International Journal of Infectious Diseases
57. Effectiveness of COVID-19 vaccines on hospitalization and death in Guilan, Iran: a test-negative case-control study
    Abtin Heidarzadeh, Mohammadreza Amini Moridani, Saman Khoshmanesh, Samira Kazemi, Marziyeh Hajiaghabozorgi, Manoochehr Karami · 2022 · International Journal of Infectious Diseases
58. The need for global access to biomedical innovations during pandemics
    Rajesh Gupta · 2021 · Nature Biotechnology
59. Effectiveness of COVID-19 vaccination among people living with HIV during a COVID-19 outbreak
    Kuan‐Yin Lin, Pei‐Ying Wu, Wang-Da Liu, Hsin‐Yun Sun, Szu‐Min Hsieh, Wang‐Huei Sheng, Yu‐Shan Huang, Chien‐Ching Hung, Shan‐Chwen Chang · 2022 · Journal of Microbiology Immunology and Infection
60. COVID-19 Infection in Children, Infants and Pregnant Subjects: An Overview of Recent Insights and Therapies
    Giuseppina Malcangi, Alessio Danilo Inchingolo, Angelo Michele Inchingolo, Luigì Santacroce, Grazia Marinelli, Antonio Mancini, Luigi Vimercati, Maria Elena Maggiore, Maria Teresa D’Oria, Denisa Hazballa et al. · 2021 · Microorganisms
61. Immunogenicity of a Heterologous Prime-Boost COVID-19 Vaccination with mRNA and Inactivated Virus Vaccines Compared with Homologous Vaccination Strategy against SARS-CoV-2 Variants
    Ruiqi Zhang, Danlei Liu, Ka‐Yi Leung, Yujing Fan, Lu Lu, Pui-Chun Chan, Kelvin Kai‐Wang To, Honglin Chen, Kwok‐Yung Yuen, Kwok‐Hung Chan et al. · 2022 · Vaccines
62. SARS-CoV-2–Specific Vaccine Candidates; the Contribution of Structural Vaccinology
    Su Min Pack, Peter J. Peters · 2022 · Vaccines
63. COVID-19 vaccination efficacy in numbers including SARS-CoV-2 variants and age comparison: a meta-analysis of randomized clinical trials
    Marharyta Sobczak, Rafał Pawliczak · 2022 · Annals of Clinical Microbiology and Antimicrobials
64. COVID-19 Vaccination in Korea
    Wan Beom Park, Young Hoon Hwang, Hee Jin Cheong · 2023 · Infection and Chemotherapy
65. Challenges and Prospects in Developing Future SARS-CoV-2 Vaccines: Overcoming Original Antigenic Sin and Inducing Broadly Neutralizing Antibodies
    John Parker Evans, Shan‐Lu Liu · 2023 · The Journal of Immunology
66. Modulation of antigen delivery and lymph node activation in nonhuman primates by saponin adjuvant saponin/monophosphoryl lipid A nanoparticle
    Parisa Yousefpour, Yiming J. Zhang, Laura Maiorino, Mariane B. Melo, Mariluz A. Arainga Ramirez, Sidath C. Kumarapperuma, Peng Xiao, Murillo Silva, Na Li, Katarzyna Kaczmarek Michaels et al. · 2024 · PNAS Nexus
67. Emerging issues related to COVID-19 vaccination in patients with cancer
    Kamal S. Saini, Diogo Alexandre Martins-Branco, Marco Tagliamento, Laura Vidal, Navneet Singh, Kevin Punie, Monika Lamba Saini, Isagani M. Chico, Giuseppe Curigliano, Evandro de Azambuja et al. · 2021 · Oncology and Therapy
68. Coronavirus disease 2019 vaccination in transplant recipients
    Christiane Sigrid Eberhardt, Elisa Balletto, Markus Cornberg, Małgorzata Mikulska · 2021 · Current Opinion in Infectious Diseases
69. Achieving global equity for COVID-19 vaccines: Stronger international partnerships and greater advocacy and solidarity are needed
    John Peter Figueroa, Peter Jay Hotez, Carolina Batista, Yanis Ben Amor, Önder Ergönül, Sarah C. Gilbert, Mayda Gürsel, Mazen M. Hassanain, Gagandeep Kang, David C. Kaslow et al. · 2021 · PLoS Medicine
70. Update on Coronavirus 2019 Vaccine Guidelines for Transplant Recipients
    Vivek Balkrishna Kute, Hari Shankar Meshram, Ashish Sharma, Arpita Ray Chaudhury, S Sudhindran, Alla Gopala Krishna Gokhale, Milind Padmakar Hote, Randeep Guleria, Devinder Singh Rana, Jai Prakash et al. · 2021 · Transplantation Proceedings
71. Evaluating the Neutralizing Ability of a CpG-Adjuvanted S-2P Subunit Vaccine Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern
    Chia-En Lien, Tsun‐Yung Kuo, Yi‐Jiun Lin, Wei‐Cheng Lian, Meei‐Yun Lin, Luke Tzu-Chi Liu, Jinyi Cheng, Yu‐Chi Chou, Charles Chen · 2021 · Clinical Infectious Diseases
72. Evaluating Antibody Mediated Protection against Alpha, Beta, and Delta SARS-CoV-2 Variants of Concern in K18-hACE2 Transgenic Mice
    Ting Y. Wong, Alexander M. Horspool, Brynnan P. Russ, Chengjin Ye, Katherine S. Lee, Michael T. Winters, Justin R. Bevere, Olivia A. Miller, Nathaniel A. Rader, Melissa Cooper et al. · 2022 · Journal of Virology
73. Defining the determinants of protection against SARS-CoV-2 infection and viral control in a dose-down Ad26.CoV2.S vaccine study in nonhuman primates
    Daniel Y. Zhu, Matthew J. Gorman, Dansu Yuan, Jingyou Yu, Noe B. Mercado, Katherine McMahan, Erica N. Borducchi, Michelle A. Lifton, Jinyan Liu, Felix Nampanya et al. · 2022 · PLoS Biology
74. Bioengineering Strategies for Developing Vaccines against Respiratory Viral Diseases
    Shalini Iyer, Rajesh Thangavel Yadav, Smriti Agarwal, Shashank Tripathi, Rachit Agarwal · 2021 · Clinical Microbiology Reviews
75. The current status of COVID-19 vaccines. A scoping review
    Manuel Rueda-Fernández, Lucía Melguizo‐Rodríguez, Victor Javier Costela-Ruiz, Anabel González‐Acedo, Javier Ramos‐Torrecillas, Rebeca Illescas Montes · 2022 · Drug Discovery Today
76. Efficacy and Safety of the CVnCoV SARS-CoV-2 mRNA Vaccine Candidate: Results from Herald, a Phase 2b/3, Randomised, Observer-Blinded, Placebo-Controlled Clinical Trial in Ten Countries in Europe and Latin America
    Kremsner, Peter G., Guerrero, Rodolfo Andrés Ahuad, Arana, Eunate, Aroca Martinez, Gustavo Jose, Bonten, Marc J.M., Chandler, Reynaldo, Corral, Gonzalo, De Block, Eddie Jan Louis, Ecker, Lucie, Gabor, Julian Justin et al. · 2021
77. Developing an Effective Peptide-Based Vaccine for COVID-19: Preliminary Studies in Mice Models
    Haiqiang Yang, Jessica A. Cao, Xiaoyang Lin, Jingwen Yue, Tarek Zieneldien, Janice Kim, Lianchun Wang, Jianmin Fang, Ruo‐Pan Huang, Yun Bai et al. · 2022 · Viruses
78. Reporting and data sharing level for COVID-19 vaccine trials: A cross-sectional study
    Yuting Duan, Jingyuan Luo, Lingyun Zhao, Xuan Zhang, Jiangxia Miao, David Moher, Zhaoxiang Bian · 2022 · EBioMedicine
79. Detection, prevention and treatment of COVID‐19 and opportunities for nanobiotechnology
    Qing Bao, Tao Yang, Mingying Yang, Chuanbin Mao · 2022 · Open Research (University of Surrey)
80. Benefit–risk evaluation of COVID-19 vaccination in special population groups of interest
    Paul A. H. Moss, Françis Berenbaum, Giuseppe Curigliano, Ayelet Grupper, Thomas Berg, Shanti Pather · 2022 · Vaccine
81. Unpacking adverse events and associations post COVID-19 vaccination: a deep dive into vaccine adverse event reporting system data
    Yiming Li, Sori Kim Lundin, Jianfu Li, Wei Tao, Yifang Dang, Yong Chen, Cui Tao · 2023 · Expert Review of Vaccines
82. Prime hAd5 Spike + Nucleocapsid Vaccination Induces Ten-Fold Increases in Mean T-Cell Responses in Phase 1 Subjects that are Sustained Against Spike Variants
    Peter A. Sieling, Thomas B. King, Raymond M.H. Wong, Andy Nguyen, Kamil Wnuk, Elizabeth Gabitzsch, Adrian Rice, Helty Adisetiyo, Melanie Hermreck, Mohit Verma et al. · 2021 · medRxiv
83. Pfizer COVID vaccine protects against worrying coronavirus variants
    Ewen Callaway · 2021 · Nature
84. The COVID‐19 vaccine: Attitudes and vaccination in patients with autoimmune inflammatory rheumatic diseases
    Jiali Chen, Wenxin Cai, Tian Liu, Yunshan Zhou, Yuebo Jin, Yue Yang, Shi Chen, Kun Tang, Chun Li · 2022 · Rheumatology & autoimmunity
85. Heterologous saRNA Prime, DNA Dual-Antigen Boost SARS-CoV-2 Vaccination Elicits Robust Cellular Immunogenicity and Cross-Variant Neutralizing Antibodies
    Adrian Rice, Mohit Verma, Emily A. Voigt, Peter Battisti, Samuel Beaver, Sierra Reed, Kyle Dinkins, Shivani Mody, Lise Zakin, Shiho Tanaka et al. · 2022 · Frontiers in Immunology
86. Host genetic diversity and genetic variations of SARS-CoV-2 in COVID-19 pathogenesis and the effectiveness of vaccination
    Mahda Delshad, Mohammad‐Javad Sanaei, Atieh Pourbagheri‐Sigaroodi, Davood Bashash · 2022 · International Immunopharmacology
87. SARS-CoV-2 Variants, Current Vaccines and Therapeutic Implications for COVID-19
    Hongyu Liang, Yuyan Wu, Vicky Yau, Huan-Xin Yin, Scott Lowe, Rachel Bentley, Mubashir Ayaz Ahmed, Wenjing Zhao, Chenyu Sun · 2022 · Vaccines
88. The Promise of Emergent Nanobiotechnologies for In Vivo Applications and Implications for Safety and Security
    Anne M. Arnold, Ashley M. Bradley, Karen Taylor, Zachary C. Kennedy, Kristin M. Omberg · 2022 · Health Security
89. Amphiphile-CpG vaccination induces potent lymph node activation and COVID-19 immunity in mice and non-human primates
    Lochana M. Seenappa, Aniela Jakubowski, Martin Peter Steinbuck, Erica Palmer, Christopher M. Haqq, Crystal Carter, Jane A. Fontenot, Francois J. Villinger, Lisa Kristin McNeil, Peter C. DeMuth · 2022 · npj Vaccines
90. Efficacy and Safety of COVID-19 Vaccines—An Update
    Eshani Sharma, Sraddha Revinipati, Saisha Bhandari, Sejal Thakur, Shubham Goyal, Aruni Ghose, Sukrit Bajpai, Waleed Muhammad, Stergios Boussios · 2022 · Diseases
91. Nanoparticles in Subunit Vaccines: Immunological Foundations, Categories, and Applications
    Jiale Liang, Lan Yao, Zhiqiang Liu, Ye Chen, Yunfeng Lin, Taoran Tian · 2024 · Small
92. Analysis of Delayed Vaccination Regimens: A Mathematical Modeling Approach
    Gilberto González‐Parra · 2021 · Epidemiologia
93. Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses
    Belén Aparicio, Noëlia Casares, Josune Egea, Marta Ruiz, Diana Llópiz, Sheila Maestro, Cristina Olagüe, Gloria González‐Aseguinolaza, Cristian Smerdou, Ascensión López-Dı́az de Cerio et al. · 2021 · Emerging Microbes & Infections
94. SARS-CoV-2 reinfections during the first three major COVID-19 waves in Bulgaria
    Georgi K. Marinov, Mladen Mladenov, Antoni Rangachev, Ivailo Alexiev · 2022 · PLoS ONE
95. An Attention towards the Prophylactic and Therapeutic Options of Phytochemicals for SARS-CoV-2: A Molecular Insight
    Shoaib Shoaib, Mohammad Azam Ansari, Geetha Kandasamy, Rajalakshimi Vasudevan, Umme Hani, Waseem Chauhan, Maryam S. Alhumaidi, Khadijah A. Altammar, Sarfuddin Azmi, Wasim Ahmad et al. · 2023 · Molecules
96. Combating Emerging Respiratory Viruses: Lessons and Future Antiviral Strategies
    Palaniyandi Muthukutty, Jaime MacDonald, So Young Yoo · 2024 · Vaccines
97. Immunology of SARS-CoV-2 infections and vaccines
    Dominik Schenten, Deepta Bhattacharya · 2021 · Advances in immunology
98. The Role of Serology Testing in the Context of Immunization Policies for COVID-19 in Latin American Countries
    Carlos dos Santos Ferreira, Héctor Gómez Dantés, Nancy Bellei, Eduardo Luis López, Katya A. Nogales Crespo, Miguel O’Ryan, Julieta Villegas · 2021 · Viruses
99. COVID-19 vaccines: Update of the vaccines in use and under development
    Rafaela Angotti Marta, Gisele Emy Kondo Nakamura, Bruno de Matos Aquino, Paulo Roberto Bignardi · 2022 · Vacunas
100. Novel coronavirus mutations: Vaccine development and challenges
     Wan-Rong Luo, Xiaomin Wu, Wei Wang, Junling Yu, Qingqing Chen, Xue Zhou, Xiner Huang, Hai‐Feng Pan, Zhirong Liu, Yong Gao et al. · 2022 · Microbial Pathogenesis